Comment Letters

Advocacy Action Items

• Grassroots Toolkit for the DOJ Anticompetitive Regulations Task Force Request for Public Comment

MH and SUDs Legislation, Funding, and Regulation

• MHLG Mental Health Parity Act Letter of Support: November 4, 2025
• MHLG SUPPORT Act Thank You Letter: October 16, 2025
• AAPP-Stakeholders Urge DEA to Update Registration Process and Authorization by State Table: September 22, 2025
• MHLG Letter of Support for Barriers to Suicide Act: September 16, 2025
• 2026 Physician Fee Schedule Comment Letter: September 12, 2025
• MHLG Letter to SAMHSA to Release FY2025 Funding: September 10, 2025
• Senate LHHS Proposal Sign-on Letter: September 2, 2025  
• Letter Urging the Reauthorization of HRSA's Title VII and VIII Programs: August 19, 2025
• MHLG Supports Telemental Health Care Access Act: August 11, 2025
• MHLG Urges 988 LGBTQ+ Service Continuation: June 24, 2025
• Letter to the Senate on Medicare Physician Fee Schedule: June 23, 2025
• MHLG Letter Supporting Suicide Prevention Act: May 29, 2025
• MHLG COMPLETE Care Act Letter: May 27, 2025
• MHLG Fiscal Year 2026 Appropriations Recommendations: May 12, 2025
• Supporting SF Buprenorphine Stocking Ordinance: May 8, 2025
• Letter Supporting Project PAUSE’s FY26 Appropriations Requests: May 2, 2025
• Letter on 5-Star Long-Stay Nursing Home Antipsychotic Use Quality Measure: April 9, 2025
• AAPP Urges Support Act Reauthorization: April 7, 2025
• DEA MOUD Letter: March 3, 2025
• MHLG Welcomes Robert F. Kennedy, Jr.: February 28, 2025
• Comments on Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program: January 20, 2025
• 2024 CMS Medicaid Parity Comments: December 2, 2024
• Letter Supporting Reentry Act and Due Process Continuity of Care Act: November 18, 2024
• Kid PROOF Coalition Letter: November 14, 2024
• Support for Modernizing Opioid Treatment Access Act (MOTAA): November 12, 2024
  • Explaining the Modernizing Opioid Treatment Access Act-MOTAA
  • Take Action on Modernizing Opioid Treatment Access Act-MOTAA
• COMPLETE Care Coalition Support Letter: November 12, 2024
• AAPP Response to Tonko and Turner on MOUD Access Post MAT Act: November 6, 2024
• Health Resources and Services Administration Workforce Development Programs: A Budget Blueprint for Fiscal Year 2025
• Letter Asking CMS to Improve Access to Maternal Health Care for Pregnant and Postpartum Individuals who Use Substances: September 9, 2024
• Letter Supporting CCBHC Expansion Grants in FY 2025: June 24, 2024
• Letter to DHHS Requesting to Finalize 2023 Proposed Parity Regulations: June 20, 2024
• AAPP Comments to CMS's RFI Regarding Medicare Advantage Data: May 28, 2024
• PEERS in Medicare Act Letter of Support: May 10, 2024
• MHLG Medicaid Bump Act Coalition Letter of Support: May 1, 2024
• MHLG Appropriations Recommendations for Fiscal Year 2025
• Letter Seeking Greater Data Collection on Incentivizing Integrated Behavioral Healthcare: April 24, 2024
• AAPP Signs Letter to Senate Finance Committee Urging the Addition of Psychiatric Pharmacists as QHPs: April 9, 2024
• AAPP Signs onto Letter Encourging the Passing of S. 3393 - the SUPPORT for Patients and Communities Reauthorization Act and S. 644 - the Modernizing Opioid Treatment Access Act (“MOTAA”): March 15, 2024
• Comment Letter to CMS in Response to the Calendar Year 2025 Advance Notice for the Medicare Advantage and Medicare Part D Prescription Drug Programs: March 1, 2024
• AAPP Joins 147 Groups Urging Congress to Enact Equitable Community Access to Pharmacist Services Act (ECAPs): February 28, 2024
• MHLG SUPPORT Act Letter: February 9, 2024
• MHLG Endorses Kid Providing Resources for Optimal Outcomes Against Fatalities (Kid PROOF) Act: February 8, 2024
• Coalition Letter Supporting Veterans Mental Health Legislation: January 12, 2024
• Call to CMS to Update Quality Measures for Antipsychotic Use in Nursing Homes: December 26, 2023
• Comment Letter to CMCS on Parity in Medicaid and CHIP: November 27, 2023
• MHLG Letter of Support for Better Mental Healthcare Lower Cost Drugs and Extenders Act: November 8, 2023
• AAPP Urges Senate Finance Committee to Add Psychiatric Pharmacists as Qualified Health Providers: November 8, 2023
• AAPP Joins Organizations to Call on the Senate to Advance and Expand the SUPPORT Act: November 2, 2023
• MHLG Urges SUPPORT Act Reauthorization: October 30, 2023
• MHLG Comments on Proposed Rules to the Federal Parity Act: October 17, 2023
• Letter to Office of National Drug Control Policy with Sublocade REMS Concerns: October 4, 2023
• Comments on Requirements Related to the Mental Health Parity and Addiction Equity Act: September 27, 2023
• Letter to CMS on Antipsychotic Quality Measures: September 27, 2023
• Letter to House of Representatives on SUPPORT Act: September 25, 2023
• Letter to CMS on 2025 Part D Redesign: September 11, 2023
• Talking Points-Modernizing Opioid Treatment Access Act
• Support of the Due Process Continuity of Care Act: June 8, 2023
• Support for the Better Mental Health Care for Americans Act: May 23, 2023
• AAPP Urges SAMHSA to Recognize ACPE in MATE Act Guidance: May 19, 2023
• MHLG Letter of Support for Pursuing Equity in Mental Health Act: May 18, 2023
• Modernizing Opioid Treatment Access Act (the “M-OTAA”) Endorsement: May 16, 2023
• DEA Letter on Stimulant Shortages: May 12, 2023
• SUPPORT Full-Spectrum Addiction Care: May 10, 2023
• Full Spectrum Addiction Care Congressional Briefing Support: May 10, 2023
• Reentry Act Endorsement: April 17, 2023
• FY2024 Labor HHS Appropriations Bill Letter: April 3, 2023
• Letter to DEA Requesting Extended Flexibilities for Telehealth Prescribing of Buprenorphine Using PHE: March 31, 2023
• Comments on Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation: March 30, 2023
• Comments on Expansion of Induction of Buprenorphine via Telemedicine Encounter: March 30, 2023
• Letter of Concern on DEA Telemedicine Rules: March 29, 2023
• Comments on DEA Rule on Telemedicine Prescribing of Controlled Substances: March 28, 2023
• MHLG FY2024 Appropriations Recommendations
• Letter of Support to House for Modernizing Opioid Treatment Access Act: March 17, 2023
• Letter of Support to Senate for Modernizing Opioid Treatment Access Act: March 17, 2023
• Letter to Senate HELP Committee on Workforce RFI: March 20, 2023
• Comments on Block, Report, And Suspend Suspicious Shipments Act: March 17, 2023
• Comments on CMS's Proposed Prior Authorization Processes Rule: March 13, 2023
• DATA-2000 Waiver Comments: March 10, 2023
• Project Pause Press Release on Need for Data-Based Reforms to Support Care for Patients with Dementia: February 21, 2023
• Comments on CMS Proposed Rule on Contract Year 2024: February 13, 2023
• MHLG Letter to Light the White House Green: February 10, 2023
• Comments on SAMHSA's Proposed Rule on Medications for the Treatment of Opioid Use Disorder: February 10, 2023
• Comments on Confidentiality of Substance Use Disorder Patient Records: January 31, 2023
• Impact of Mainstreaming Addiction Treatment (MAT) Act
• MHLG 2022 End of Year Priorities Letter: November 30, 2022
• Support for Mainstreaming Addiction Treatment Act: November 29, 2022
• MHLG Organizations Support Behavioral Health Workforce for the Future Act: November 23, 2022
• Comments on Senate HELP Committee Package: November 17, 2022
• Comments on Enhancing the Mental Health Workforce Discussion Draft: November 15, 2022
• Comments on Person-Centered Care Planning for Multiple Chronic Conditions: November 11, 2022
• Comments to Enhance the Mental Health Workforce Discussion Draft: November 10, 2022
• Comments on Draft Recommendation Statement on Screening for Depression and Suicide Risk in Adults: October 17, 2022
• Support for Law Enforcement De-Escalation Training Act: October 14, 2022
• AAPP Joins Coalition in Sounding Alarm on Youth Mental Health: October 13, 2022
• Request for Chapter Amendments to A.3040-B-Authorizing Pharmacists to Administer LAIs: September 14, 2022
• Cures Package Recommended by AAPP and Partners: September 7, 2022
• Support for MAT Act: August 31, 2022
• AAPP Comments on HHS Initiative to Strengthen Primary Health Care RFI: August 1, 2022
• Support for Collaborative Care Model: July 27, 2022
• MHLG Organizations Support Safer Communities Act: July 21, 2022
• Support for S.4448, the Suicide Prevention Act: July 15, 2022
• Support for Expanding Access to Mental Health Training Act: July 14, 2022
• Parity-Inclusion of USDOL penalty authority: July 13, 2022
• Support for Improving Access to Behavioral Health Integration Act: July 6, 2022
• Support for Bipartisan Safer Communities Package: June 23, 2022
• Support for Ending Harmful Opt Outs From Federal Mental Health Parity Requirememnts: May 17, 2022
• MHLG Organizations Support Parity Implementation Assistance Act: May 16, 2022
• Support for MAT Act Provision in Restoring Hope for Mental Health and Well-Being Act: May 13, 2022
• Comments on CDC Draft Clinical Guidelines for Prescribing Opioids: April 8, 2022
• Support for Law Enforcement De-Escalation Training Act: April 5, 2022
• MHLG Organizations Support Prior Authorization Reform: April 5, 2022
• MHLG Organizations Support 988 Implementation Act: February 18, 2022
• Health Coverage Parity for Mental Health and Substance Use Disorders: February 15, 2022
• CPNP Joins MHLG Organizations Urging Congress to Pass Appropriations Bill to Increase Funding for Mental Health and Substance Use Services: February 7, 2022
• CPNP Joins National Organizations Calling on the FDA to to Retract its Safety Communication Regarding Buprenorphine: January 24, 2022
• CPNP Joins National Organizations Urging Congress to Address Drug Overdose Epidemic: November 30, 2021
• CPNP Joins MHLG Organizations Supporting 988 Crisis Care Continuum: November 22, 2021
• CPNP and Members of the Health Professions and Nursing Education Coalition Urging Congress to Provide Funding for the Health Resources and Services Administration (HRSA) Title VII Health Professions and Title VIII Nursing Workforce Development Programs for Fiscal Year 2022: November 22, 2021
• CPNP Joins MHLG Organizations Providing Feedback to Senate Finance RFI: November 15, 2021
• CPNP Joins Health Organizations Submitting Comments to the Senate Finance Committee's RFI: November 15, 2021
• CPNP Responds to Cassidy/Murphy Request for Bipartisan Policy Recommendations to Address Mental Health and SUDs: November 5, 2021
• CPNP Joins Health Organizations Supporting H.R.5218: November 9, 2021
• CPNP Responds to Wyden/Crapo's Request for Policy Proposals to Address Unmet Mental Health Needs: November 1, 2021
• CPNP Joins MHLG Organizations Supporting the Pursuing Equity in Mental Health Act: October 13, 2021
• CPNP Joins MHLG Organizations Supporting the TRIUMPH for New Moms Act: October 12, 2021
• CPNP Joins MHLG Organizations Urging Senators Wyden and Crapo to Fully extend the Federal Parity Act to Medicare and all of Medicaid: October 8, 2021
• CPNP Joins MHLG Organizations Urging Senators Bennet and Cornyn to Fully extend the Federal Parity Act to Medicare and all of Medicaid: October 8, 2021
• CPNP Responds to Bennet/Cornyn's A Bold Vision for America’s Mental Well-being white paper: October 8, 2021
• CPNP Joins MHLG Organizations in supporting the Veteran Peer Specialist Act: October 5, 2021
• CPNP Joins MHLG Organizations Supporting Build Back Better: September 29, 2021
• CPNP Joins MHLG Organizations Supporting S. 1902, the Behavioral Health Crisis Services Expansion Act: September 29, 2021
• CPNP Joins MHLG Organizations Supporting the Taskforce Recommending Improvements for Unaddressed Mental Perinatal & Postpartum Health (TRIUMPH) for New Moms Act: September 28, 2021
• CPNP Joins Health Care Organizations Thanking Chairman Scott for Inclusion of Provisions in Build Back Better Act: September 22, 2021
• Request for National Suicide Prevention Lifeline in the Fiscal Year 2022 Continuing Resolution: September 17, 2021
• CPNP Joins MHLG Organizations Supporting Moms Matter Act to the Senate: September 10, 2021
• CPNP Joins Health Care Organizations Supporting Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 (Federal Parity Act): September 10, 2021
• CPNP Joins MHLG Organizations Supporting Moms Matter Act: August 23, 2021
• CPNP Joins MHLG Organizations Supporting Pursuing Equity in Mental Health Act: July 22, 2021
• CPNP Joins MHLG Organizations Supporting Parity Implementation Assistance Act: July 21, 2021
• CPNP Joins Health Care Organizations Supporting Removal of Federal X-Waiver: July 13, 2021
• CPNP Joins MHLG Organizations Supporting the Excellence in Mental Health and Addiction Treatment Expansion Act: July 7, 2021
• CPNP Joins Health Care Organizations Supporting Medicaid Reentry Act: June 30, 2021
• CPNP Joins MHLG Organizations Supporting the Medicaid Bump Act: June 21, 2021
• CPNP Joins Health Care Organizations Supporting the Mainstreaming Addiction Treatment Act: May 12, 2021
• CPNP Joins Health Care Organizations Urging HHS and DOJ to Update PDMP Policies: May 10, 2021
• CPNP Joins Health Care Organizations Supporting The Moms Matter Act: May 7, 2021
• CPNP Joins MHLG Organizations Urging the House Energy and Commerce Committee to Pass Mental Health Legislation: May 5, 2021
• CPNP Joins Health Care Organizations Supporting the McDonald/Breslin Legislation Authorizing Pharmacists in the State of New York to Administer Long Acting Injectable Medications: May 5, 2021
• CPNP Urges HHS and SAMHSA to Include Psychiatric Pharmacists as Exempt Buprenorphine Providers: May 4, 2021
• CPNP Supports Funding for Substance Use and Mental Health Programs in FY2022 Labor-HHS-Education Bill: April 28, 2021
• CPNP Joins MHLG Organizations Supporting the President’s Request for MH and SUD Program: April 23, 2021
• CPNP Joins MHLG Organizations Supporting the Effective Suicide Screening and Assessment in the ED Act: April 21, 2021
• CPNP Joins MHLG Organizations Supporting the Parity Enforcement Act to Allow the DOL to Assess Penalties for Plans that Violate the Federal Parity Act: April 14, 2021
• CPNP Joins MHLG Organizations Spporting the Mental Health Professionals Workforce Shortage Loan Repayment Act: April 13, 2021
• CPNP Joins Health Care Organizations Urging HHS Secretary to Take Immediate Action to Combat Addiction Crisis: April 13, 2021
• CPNP Joins MHLG Organizations Requesting Fiscal Year 2022 Appropriations: April 7, 2021
• CPNP Joins Health Care Organizations Urging the Department of Education to Provide Guidance to Schools on Use of ARP Funding for Student Mental Health: April 6, 2021
• CPNP Joins Health Care Organizations Urging Congress to Provide Funding for HRSA Title VII Health Professions and Title VIII Nursing Workforce Development Programs for FY 2022: March 31, 2021
• CPNP Joins MHLG Organizations Thanking President Biden for MH and SUD Funding in the American Rescue Plan: March 24, 2021
• CPNP Joins MHLG Organizations Thanking House and Senate Leadership for MH and SUD Funding in the American Rescue Plan: March 24, 2021
• CPNP Joins MHLG Organizations Supporting the Pursuing Equity in Mental Health Act: March 12, 2021
• CPNP Joins MHLG Organizations Supporting the COVID-19 Mental Health Research Act: March 4, 2021
• CPNP Joins MHLG Organizations Supporting Mental Health Services for Students Act: March 2, 2021
• CPNP Joins Health Organizations Opposing Formulary Flexibilities for Medicare Part D Plans: February 25, 2021
• CPNP Joins Health Organizations Supporting Medicaid Reentry Act: February 24, 2021
• CPNP Urges House of Representatives to Eliminate Buprenorphine Prescribing Requirements in Mainstreaming Addiction Treatment Act: February 17, 2021
• CPNP Urges Senate to Eliminate Buprenorphine Prescribing Requirements in Mainstreaming Addiction Treatment Act: February 17, 2021
• CPNP Joins MHLG Organizations Supporting Coronavirus Mental Health and Addiction Assistance Act of 2021: February 10, 2021
• CPNP Joins Pharmacy Associations Opposing Weakening Statutory Patient Protections Under PDM Model: February 10, 2021
• CPNP Joins Health Organizations Responding to CMMI Part D Payment Modernization Models: February 4, 2021
• CPNP Joins MHLG Organizations Supporting Barriers to Suicide Act: February 1, 2021
• CPNP Joins MHLG Organizations Thanking CAA for Supporting Mental Health and SUDs Funding: January 28, 2021
• CPNP Comments on SUPPORT Act of 2018: Dispensing and Administering Controlled Substances for MAT: December 22, 2020
• CPNP Joins MHLG Organizations Addressing MH and SUD Effects of COVID-19: December 1, 2020
• CPNP Partners with SPPCP Supporting Mainstreaming Addiction and Treatment Act: November 9, 2020
• CPNP Joins MHLG Organizations Supporting Legislation to Help Prevent Youth Suicide: September 30, 2020
• CPNP Joins MHLG Organizations Urging the House of Representatives to Help Prevent Youth Suicide: September 21, 2020
• CPNP Joins MHLG Organizations Supporting SAMHSA Funding: August 28, 2020
• CPNP Joins MHLG Organizations Urging Congress to Advance National Suicide Hotline Designation Act: July 22, 2020
• CPNP Joins MHLG in Supporting Federal Medical Assistance Percentage (FMAP): June 25, 2020
• CPNP Supports Research on MH Consequences of COVID-19: June 10, 2020
• CPNP Joins MHLG Coalition Requesting Inclusion of Suicide Prevention and Youth Mental Health Policies and Funding: May 11, 2020
• CPNP Submits Comments to DEA Supporting Mobile Units for Increased Access to MAT: April 21, 2020
• HPNEC Budget Blueprint for Fiscal Year 2021: March 24, 2020
• CPNP Urges Policymakers to Protect Mental Health and Substance Use Services: March 20, 2020
• CPNP Joins MHLG Coalition Urging Policymakers to Address MH Implications of Public Health Crisis: March 5, 2020
• CPNP Joins MHLG on Appropriations Requests: March 1, 2020
• CPNP Joins MHGL Coalition Supporting Seeding Rural Resilience Act: February 2020

Federal Funding and Actions

• MHLG Letter to CMS on H.R.1 Work Requirements to Protect Individuals with MH/SUD: December 17, 2025
• HPNEC FY 2026 Appropriations Letter: November 5, 2025
• Extension of enhanced health care tax credits urged by MHLG: September 23, 2025
• MHLG Letter on FY2026 Labor HHS Appropriations Bill: September 2, 2025
• Letter Raising Concerns About FDA’s Review of SSRIs and Pregnancy: August 18, 2025
• MHLG Letter on Medicaid and Budget Reconciliation: June 30, 2025
• Letter to Senate on Impact of Medicaid Cuts to Women and Children: June 25, 2025
• Letter to HELP Leaders Regarding Student Loan Reconciliation Provisions: June 24, 2025
• Letter to Senate to Remove Higher Education Provisions from Big Beautiful Bill: June 17, 2025
• Health Care Community Letter on Higher Ed Provisions in the Senate Reconciliation Bill: June 17, 2025
• MMA Letter to Senate Leadership on Medicaid Cuts: June 12, 2025
• MHLG letter to Senate Finance and Budget Committee Leadership on Medicaid: June 10, 2025
• MHLG Letter to the Senate Supporting SAMHSA: June 10, 2025
• MHLG Letter to the House Supporting SAMHSA: June 10, 2025
• Cuts to NIH Budget a Significant Concern: June 5, 2025
• Project PAUSE Letter to LHHS Appropriations Subcommittee: May 22, 2025
• Letter to HHS Concerning Reductions in Force: April 29, 2025
• Letter to Appropriators on HHS FY26 Cuts: April 25, 2025
• Letter to HHS Regarding SAMHSA and the Administration on Community Living (ACL): April 23, 2025
• AAPP Statement on MAHA Commission: April 22, 2025
• Clinical Pharmacist Legislative Initiative Letter: April 9, 2025
• AAPP Supports SAMHSA’s Vital Role: April 7, 2025
• Letter to VA Secretary Collins Emphasizes Importance of MH Clinical Pharmacists: April 4, 2025
• Letter to Preserve Protections Against cuts to NIH Indirect Costs and Fund NIH Sufficiently: February 20, 2025
• MHLG Welcome Letter to House Energy & Commerce Committee: February 5, 2025
• MHLG Support to Protect Medicaid as the Largest Payer of Mental Health and SUD Services: January 29, 2025

Psychiatric Pharmacist Scope of Practice

• Pharmacy Associations Provide Statement Proposing Integrated Payment Model Using Clinical Pharmacists in Coordinated Healthcare Teams: June 13, 2024
• AAPP Joins Pharmacy Associations Supporting Legislation to Ensure Senior Access to Essential Pharmacist Services: February 28, 2024
• AAPP Joins Pharmacy Associations Urging Continuation of Pharmacist Patient Care Services Post PHE: March 3, 2023
• AAPP Joins Over 50 Pharmacy Organizations Urging CMS Action: December 15, 2022
• Health Organizations Request PREP Act Declaration for Monkeypox: August 19, 2022
• Welcome Letter to Dr. Ashish Jha: April 19, 2022
• Comments on AHRQ's Strategic Framework: April 8, 2022
• Support for Equitable Community Access to Pharmacist Services Act (ECAPS): March 25, 2022
• Pharmacist Groups Call on Biden Administration to Remove Limits on Prescribing COVID Treatments: March 8, 2022
• CPNP Joins Pharmacy Organizations Responding to CMS's Guidance to Not Require Payment to Pharmacists for COVID19 Anitvirals: November 30, 2021
• CPNP Joins Health Organizations Urging HHS and CMS to Allow Medicare and Medicaid Programs to Reimburse Pharmacists for Patient Assessment Services: November 2, 2021
• CPNP Joins Health Organizations Supporting PREP Act to Improve Patient Access to Time-Sensitive Influenza Therapies: October 28, 2021
• CPNP Joins Health Organizations Supporting the PREP Act for COVID-19 to Allow Pharmacists to Administer REGEN-COV: August 19, 2021
• CPNP Joins Health Organizations Welcoming CMS Administrator Chiquita Brooks-LaSure: June 23, 2021
• CPNP Joins Health Organizations Welcoming HHS Deputy Secretary Andrea Palm: May 26, 2021
• CPNP Joins Health Organizations Supporting Pharmacists and Medically Underserved Areas Enhancement Act: May 19, 2021
• CPNP Joins Pharmacy Organizations Urging DHHS to Include Pharmacists in PREP Act Expansion: February 2, 2021
• CPNP Joins Coalition Supporting LAI Administration by NY Pharmacists: November 18, 2020
• CPNP Submits Comments on Physician Fee Schedule: October 5, 2020
• CPNP Joins Pharmacy Organizations Commenting on COVID-19 Vaccine: September 4, 2020
• CPNP Joins Pharmacy Organizations Celebrating U.S. Department of Human Services for Expanding the Role of Pharmacists in Providing Vaccines to Children: August 21, 2020
• CPNP Joins Pharmacy Organizations Requesting HHS Authorize Pharmacists to Order and Administer Approved COVID-19 Vaccines: June 29, 2020
• CPNP Comments on Stregthening the Integration of Primary and Behavioral Health Care: May 29, 2020
• CPNP Joins Fellow Pharmacy Associations in Recommending Inclusion of Pharmacists in Student Loan Forgiveness: May 8, 2020
• CPNP Joins 11 National Pharmacy Organizations in HHS Letter on COVID Testing Payment: May 8, 2020
• CPNP Joins Fellow Pharmacy Associations in HHS Letter Requesting Meeting to Discuss Testing Guidance Implementation for Pharmacist COVID-19 Response: April 17, 2020
• CPNP Joins Fellow Pharmacy Associations in Medicare Testing Support Letter: April 8, 2020
• CPNP Joins Pharmacy Community in Recommending Inclusion of Pharmacists and Medically Underserved Areas Enhancement Act in COVID-19 legislation: March 20, 2020
• Pharmacist Advocacy Groups Call for New Action to Enhance COVID-19 Patient Care: March 20, 2020
• CPNP Joins 7 National Pharmacy Associations and Over 70 State Pharmacy Associations in Joint Letter to CMS Regarding Pharmacy Scope of Practice: January 17, 2020

Telehealth Legislation and Regulation

• Letter Urging OMB and DEA to Extend DEA Telemedicine Prescribing Flexibilities: December 5, 2025
• Stakeholders Request Long Term Medicare Telehealth Fix: November 4, 2025
• MHLG Letter Supporting the Extension of Medicare Telehealth Flexibilities: September 23, 2025
• Letter Requesting Medicare Telehealth Extension: August 11, 2025
• Letter to Terry Cole on Special Registration for Telemedicine: July 22, 2025
• Letter Urging the DEA to Remove Barriers to Telemedicine Prescribing: March 18, 2025
• Letter to Congressional Leadership to Preserve Telehealth: February 24, 2025
• Welcome Letter to Attorney General Pam Bondi: February 20, 2025
• Continue Teleprescribing Flexibilities For Controlled Substances
• Letter to Congressional Leaders Supporting Telehealth: December 11, 2024
• Letter to White House About DEA Telemedicine Prescribing: September 10, 2024
• Letter to House Leadership About DEA Telemedicine Prescribing: September 10, 2024
• Letter to Senate Leadership About DEA Telemedicine Prescribing: September 10, 2024
• Letter to E&C Leadership Supporting Telemental Health Care Access Act: June 18, 2024
• Letter to DEA Supporting Including Schedule IIN Medications in Telemedicine Prescribing of Controlled Substances when the Practitioner and the Patient Have not had a Prior In-Person Medical Evaluation: June 11, 2024
• Stakeholder Letter to DEA: April 1, 2024
• Stakeholder Letter to DEA: November 11, 2022
• Letter Urging OMB to Act on Special Registration for Telemedicine: October 12, 2022
• MHLG Organizations Support Advancing Telehealth Beyond COVID-19 Act of 2021: September 14, 2022
• DEA Urged to Collaborate with HHS on the Special Registration Process for the Use of Telemedicine to Prescribe Controlled Substances: March 3, 2022
• CPNP Submits Comments to DEA Supporting Telemedicine and Telepharmacy: January 18, 2022
• Payors Encouraged to Continue Coverage for Tele-mental Health Services: December 8, 2021
• CPNP Supports Telemental Health Care Access Act: November 16, 2021
• CPNP Joins Health Care Organizations Supporting Telehealth in the CY 2022 Medicare Physician Fee Schedule: September 13, 2021
• CPNP Joins Health Care Organizations Commenting on the CY 2022 Physician Fee Schedule, Audio-only Modifier Code: September 13, 2021
• CPNP Joins MHLG Organizations Commenting on the Hearing on Examining Our COVID-19 Response: May 4, 2021
• CPNP Joins MHLG Organizations Supporting the Tele-Mental Health Improvement Act: March 3, 2021
• CPNP Joins MHLG Organizations Commenting on the Hearing of the Future of Telehealth: March 1, 2021
• CPNP Joins MHLG Organizations Supporting TREAT Act: February 22, 2021
• CPNP Joins MHLG Organizations Urging Biden Administration to Expand Tele-behavioral Health Waivers in First 100 Days: January 19, 2021
• CPNP Supports Telemedicine Prescribing of Controlled Substances: December 14, 2020
• CPNP Joins MHLG Organizations Supporting Mental and Behavioral Health Connectivity Act: December 9, 2020
• CPNP Provides Support to Telehealth Bill: November 6, 2020
• CPNP Joins MHLG Organizations Supporting Telehealth Expansion: October 5, 2020
• CPNP Supports Telehealth Rural Community Act: September 25, 2020
• CPNP Joins MHLG Organizations Urging Congress to Pass Telehealth Response for E-prescribing Addiction Therapy Services (TREATS) Act: August 5, 2020
• CPNP Supports Telehealth, Enumerates Barriers to Access in Letter to CMS: July 7, 2020
• CPNP Joins 340 Organizations Urging Action on Telehealth: June 29, 2020
• CPNP Joins MHLG Coalition in Supporting Coverage of Telehealth: June 1, 2020
• CPNP Joins MHLG Coalition Requesting Telehealth Extensions Beyond Pandemic: May 22, 2020
• CPNP Joins MHLG Coalition Supporting Telemedicine Coverage: May 11, 2020
• CPNP Joins MHLG Coalition Urging DHA to Loosen Telehealth Restrictions: May 4, 2020
• CPNP Joins MHLG Coalition Urging Policymakers to Cover Telehealth Services: April 24, 2020

Other

• Public Comment Letter to Advisory Commission on Childhood Vaccines: December 19, 2025
• MHLG Letter Urging Passage of the Improving Seniors’ Timely Access to Care Act: December 9, 2025
• Letter for Request for Comments for “Advisory Committee on Immunization Practices (ACIP) December 4 - 5, 2025, Meeting”: December 4, 2025
• Letter to Advisory Committee on Immunization Practices: November 21, 2025
• Response Letter on Requesting Information on Pharmacists Providing Chronic Care: November 10, 2025
• Guiding Principles for State Policy on Pharmacy Personnel-Administered Vaccines: October 2025
• Congratulations Letter to Rep Harshbarger Harshbarger-VC of House Energy and Commerce Health Subcommittee: July 15, 2025
• Letter to BCBS Regarding Maintaining Access to Immunizations Without Patient Cost Sharing: July 7, 2025
• AAPP Prepares for MAHA Commission: February 24, 2025
• Letter Supporting Rebuild America’s Health Care Schools Act: February 7, 2025
• Joint Letter on Clozapine REMS Harms-FDA Joint Advisory Committee: November 4, 2024
• Comment Letter on 2025 PFS request for information on CCBHCs: September 9, 2024
• AAPP 2025 Physician Fee Schedule Comments: September 9, 2024
• MHLG Comment Letter Regarding the Four Walls Exception and Payment Increase for IOP and PHP: September 9, 2024
• Letter in Support of CMS’s Proposal on Digital Mental Health Treatment: September 9, 2024
• Medicare Physician Fee Schedule Comments on Integrated Care: September 9, 2024
• AAPP Participates in and Submits Comments on Benzodiazepine Tapering Guideline: July 15, 2024
• Letter to FDA Requesting Process Clarifications Related to Upcoming Meeting to Reevaluate the Clozapine REMS: June 21, 2024
• Comments to NABP/NCPA Proposed Guideline on Pharmacy Access to Resources and Medication for Opioid Use Disorder: May 2024
• HPNEC End of Year Letter on FY 24 Appropriations: January 29, 2024
• Joint Pharmacy Drug Importation Letter: January 17, 2024
• 2023 Part D Access Year in Review
• Letter to Advisory Committee on Immunization Practices on Pharmacist Representation: November 8, 2023
• Comments on CMS's Proposed Rule Related to Hospital Outpatient Prospective System Proposed Rule: September 8, 2023
• Comments on 2024 Physician Fee Schedule Proposed Rule: September 8, 2023
• AAPP Joins Tomorrow's Workforce Coalition: July 27, 2023
• AAPP Responds to FDA Request for Feedback on Reviewing Changes to REMS Administrators: July 7, 2023
• MHLG Letter Congratulating the Congressional Mental Health Caucus Co-chairs: February 21, 2023
• Comments on Revised Draft of CCBHC Certification Criteria: January 20, 2023
• AAPP Joins HPNEC Urging Congress to Provide Higher Funding: December 6, 2022
• AAPP Comments on 2023 Physician Fee Schedule: September 2, 2022
• CPNP Joins Peers in Attempts to Link Mental Illness and Gun Violence: June 6, 2022
• Information to Psychopharmacologic Drugs Advisory Committee: June 3, 2022
• BPS Advocates for Inclusion of Psychiatric Pharmacists in MHFA Curriculum: May 11, 2022
• GTMRx Supports The Right Drug Dose Now Act: February 28, 2022
• FDA Response to Extension of Clozapine REMS Suspension: February 17, 2022
• CPNP-Stakeholders Urge Extension of Clozapine REMS Suspension: February 14, 2022
• CPNP Joins Health Care Organizations Submitting Comments to the Senate Regarding Clozapine REMS and Isotretinoin: January 27, 2022
• CPNP Joins Health Care Organizations Submitting Comments to the House Regarding Clozapine REMS and Isotretinoin: January 27, 2022
• CPNP Joins Health Care Organizations Supporting Dr. Robert Califf's Nomination to Serve as FDA Commissioner: December 13, 2021
• CPNP Joins Pharmacy Stakeholders in Outreach Regarding Urgent Clozapine REMS Issues: November 18, 2021
• CPNP Joins Pharmacy Associations Offering Condolences to Families of Pharmacist and Others Killed in Maryland: October 8, 2021
• CPNP Joins Health Care Organizations Submitting Comments to the FDA Regarding Clozapine Changes: September 15, 2021
• CPNP Submits Comments to CMS Regarding CY 2022 Payment Policies Under the Physician Fee Schedule: September 13, 2021
• CPNP Joins MHLG Organizations Supporting the Nomination of Dr. Delphin-Rittmon for Assistant Secretary: June 7, 2021
• CPNP Joins Pharmacy Associations Urging HHS to Continue COVID-19 Regulatory Relief: April 22, 2021
• CPNP Joins Pharmacy Associations Urging HHS Secretary to Work on Shared Public Health Goals: March 30, 2021
• CPNP Supports Unified Vision Addressing Future of Mental Health and Substance Use Care in America: February 25, 2021
• CPNP Joins Pharmacy Associations Requesting Inclusion of Pharmacist on Health Equity Task Force: February 12, 2021
• CPNP Pens Letter to Biden Team with Recommendations Specific to Psychiatric Pharmacy: December 16, 2020
• CPNP Joins Pharmacy Associations in Providing Public Health Recommendations and Requests Meeting with Biden Transition Team: December 9, 2020
• CPNP Joins Pharmacy Organizations Collaborating on Racial Injustices: October 9, 2020
• CPNP Joins fellow Stakeholders Urging CDC to Issue Guidance Advising States to Include Mental Health and Addiction Treatment Providers: December 18, 2020
• CPNP Pens Letter to Biden Team with Recommendations Specific to Psychiatric Pharmacy: December 16, 2020
• CPNP Joins Pharmacy Associations Supporting FDA Authorization of COVID Vaccine: December 11, 2020
• CPNP Joins Pharmacy Associations in Providing Public Health Recommendations and Requests Meeting with Biden Transition Team: December 9, 2020
• CPNP Supports FY2021 Appropriations Ask for Health Professions Training to be Included in a Final Funding Package: November 24, 2020
• CPNP Joins Pharmacy Organizations Collaborating on Racial Injustices: October 9, 2020
• CPNP Joins Fellow Pharmacy Associations in Drug Importation Comments: March 9, 2020
• CPNP Supports Reauthorization of the Older Americans Act (OAA): February 7, 2020
• Letter to Pharmacy Stakeholder Letter on Value Based Care-Safe Harbors under AKS: December 31, 2019
• CPNP Supports Effective Suicide Screening and Assessment in the Emergency Department Act of 2019: December 2019
• CPNP Supports Barriers to Suicide Act of 2019: December 2019
• CPNP Supports Funding Titles VII and VIII: November 26, 2019
• CPNP Comments to Committee on Energy and Commerce on SUDs Best Practices: November 1, 2019
• Letter to CMS on Opioid Addiction and MAT Access Action Plan: October 11, 2019
• CPNP comments on mental health-gun violence-involuntary commitment: September 9, 2019
• Comments to CMS CY 2020 Revisions to Payment Policies under the Physician Fee Schedule and other Changes to Part B Payment Policies: September 27, 2019
• CPNP Congratulates Director for Substance Abuse Treatment for SAMHSA: September 3, 2019
• CPNP Congratulates CMO for SAMHSA: September 3, 2019
• CPNP and Mental Health Liaison Group Support Loan Repayment Program: July 31, 2019
• Comments to APA Schizophrenia Guideline: June 26, 2019
• Partnership for Part D Access - Part D Final Rule: May 16, 2019
• CPNP and Mental Health Liaison Group support H.R. 2021: April 11, 2019
• Pediatric Mental Health Access Grants Sign On: April 10, 2019
• Partnership for Part D Coalition Sends Letter to Secretary Azar on Protected Medication Classes: April 2, 2019
• CPNP Joins Health Groups in Opposing Medicare Part D Changes: January 25, 2019
• CPNP Supports Joint Comments on USP 1079: September 28, 2018
• MHLG Supports Legislation to Support Demonstration Project to Increase Substance Use Provider Capacity Under the Medicaid Program: September 21, 2018
• Comments on Medicare Physician Fee Schedule Rule: September 10, 2018
• CPNP Supports Mental Health Workforce Bill: August 24, 2018
• CPNP Supports Pediatric Mental Health Access Grant-Senate: April 25, 2018
• CPNP Supports Pediatric Mental Health Access Grant-House: April 25, 2018
• CPNP Supports Substance Use Disorder Workforce Loan Repayment Act: April 18, 2018
• Patient Advocacy Groups Urge HHS to Maintain Part D Protected Classes: April 9, 2018
• Comments to House Committee on Ways and Means on Opioid Crisis: March 15, 2018
• Comments to Support Budget Dedication to Mental Health and Addiction: February 23, 2018
• Comments to Support National Hotline Improvement Act: February 16, 2018
• Comments to Senate Finance Committee on Opioid Crisis: February 16, 2018
• Comments to Senate HELP Committee on MAT: February 7, 2018
• MHLG supports Sen. Warren's-Rep Kennedy Behavioral Health Coverage Transparency Act of 2018: January 26, 2018
• CMS-Innovation Center New Direction: November 20, 2017
• Support of HR 3991-DATA Waiver for Expanded MAT Access: October 25, 2017
• Comments to Commission on Opioid Epidemic: October 3, 2017
• Comments to Behavioral Health Payment and Care Delivery Innovation Summit: August 24, 2017
• Comments to Interdepartmental Serious Mental Illness Coordinating Committee: August 24, 2017
• Comments on Proposed Rule Implementing the Hospital Inpatient Prospective Payment (IPPS) for FY 2018: June 13, 2017
• CPNP Comments on Medicare Advantage and Part D Advance Notice and Draft Call Letter: March 1, 2017
• Medicare Payment Policies-Physicians Comments to CMS: August 14, 2016
• Joint Pharm Org Comments to CMS on MACRA Proposed Rule: June 27, 2016
• ClozapineREMS Letter to FDA: June 16, 2016
• Patient Stakeholders Oppose MedPAC Recommendation to Undermine Medicares Protected Classes: June 15, 2016
• CPNP Urges Inclusion of Psychiatric Pharmacists in Letter to the Editor: June 12, 2016
• CPNP/ACCP Coalition Submits Comments to Hearing Focused on “Legislation to Improve and Sustain the Medicare Program": June 6, 2016
• CPNP Comments on the Better Care, Lower Cost Act: March 11, 2016
• CPNP Comments to Sentate Finance Chronic Care Committee: January 22, 2016
• CPNP Comments on Medicare Part D Medication Therapy Management Program: October 21, 2015
• CPNP Comments on International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; Ketamine and Nine Other Substances: October 15, 2015
• Letter to FDA Regarding Inclusion of Board Certified Psychiatric Pharmacists into the Clozapine REMS Enrollment Form: September 29, 2015
• CPNP Comments on Reform of Requirements for Long-Term Care Facilities: September 14, 2015
• Senate Committee comments on Chronc Care: June 19, 2015
• May 2015-ACCP CPNP Comments Senate Finance Committee Hearing A Pathway to Improving Care for Medicare Patients with Chronic Conditions: May 14, 2015
• CPNP Response-USP General Chapter 800 Hazardous Drugs – Handling in Healthcare Settings: May 4. 2015
• CPNP Response-NIOSH Hazardous Drugs List for Classification of a Medication as Hazardous: June 17, 2014
• Letter to Congressman Tim Murphy: April 14, 2014
• PAPCC response letter to APhA: March 10, 2014
• Letter to Membership on PAPCC: March 10, 2014
• CMS Comment Letter-MTM Expansion-Drug Class Limitations: March 7, 2014
• Better Care Act Response-Sen Wyden: March 3, 2014
• CPNP Mental Health Improvement Response Letter: September 13, 2013